Gene · 5015
Papers2,975
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,975
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases. | NPJ Precis Oncol | 2024 | 39349591 | PubTator, text mining | PubMed |
| Physics-driven unsupervised deep learning network for programmable metasurface-based beamforming. | iScience | 2024 | 39246440 | PubTator, text mining | PubMed |
| Kick-starting the zygotic genome: licensors, specifiers, and beyond. | EMBO Rep | 2024 | 39160344 | PubTator, text mining | PubMed |
| Demyelination and impaired oligodendrogenesis in the corpus callosum following lead exposure. | Toxicol Sci | 2024 | 39150886 | PubTator, text mining | PubMed |
| aKNNO: single-cell and spatial transcriptomics clustering with an optimized adaptive k-nearest neighbor graph. | Genome Biol | 2024 | 39090647 | PubTator, text mining | PubMed |
| Distinct dynamics of parental 5-hydroxymethylcytosine during human preimplantation development regulate early lineage gene expression. | Nat Cell Biol | 2024 | 39080410 | PubTator, text mining | PubMed |
| Etiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene. | Endocr Connect | 2024 | 39078873 | PubTator, text mining | PubMed |
| Cross-species single-cell landscapes identify the pathogenic gene characteristics of inherited retinal diseases. | Front Genet | 2024 | 39055259 | PubTator, text mining | PubMed |
| A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing. | Nat Cell Biol | 2024 | 39025928 | PubTator, text mining | PubMed |
| Non-syndromic OTX2-associated pattern dystrophy: a 10-year multimodal imaging study. | Doc Ophthalmol | 2024 | 39023660 | PubTator, text mining | PubMed |
| Construction and Identification of a Novel Mice Model of Microphthalmia. | Transl Vis Sci Technol | 2024 | 39007834 | PubTator, text mining | PubMed |
| TGF-β modulates cell fate in human ES cell-derived foregut endoderm by inhibiting Wnt and BMP signaling. | Stem Cell Reports | 2024 | 38942030 | PubTator, text mining | PubMed |
| Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study. | Ann Clin Transl Neurol | 2024 | 38925618 | PubTator, text mining | PubMed |
| A deep learning framework for predicting disease-gene associations with functional modules and graph augmentation. | BMC Bioinformatics | 2024 | 38877401 | PubTator, text mining | PubMed |
| Transcriptional remodeling by OTX2 directs specification and patterning of mammalian definitive endoderm. | bioRxiv | 2024 | 38854146 | PubTator, text mining | PubMed |
| Establishment of an induced pluripotent stem cell line LEIi019-A from an early-onset retinal dystrophy patient with the autosomal dominant OTX2 c.259G>A variant. | Stem Cell Res | 2024 | 38852423 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Turkish Patients with Inherited Retinal Dystrophies Reveals Novel Variants in Ten Genes. | Mol Syndromol | 2024 | 38841332 | PubTator, text mining | PubMed |
| The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas. | Int J Mol Sci | 2024 | 38674001 | PubTator, text mining | PubMed |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Cells | 2024 | 38667322 | PubTator, text mining | PubMed |
| PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor. | J Neurooncol | 2024 | 38662151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5015/papers?page=7